Frequencies for first 10,000 rows of indi_pt variable in indi2010q2 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISCOMFORT | 3 0.03 0.03 ABDOMINAL DISTENSION | 2 0.02 0.05 ABDOMINAL PAIN | 3 0.03 0.08 ABDOMINAL PAIN LOWER | 1 0.01 0.09 ABDOMINAL PAIN UPPER | 3 0.03 0.12 ABNORMAL BEHAVIOUR | 1 0.01 0.13 ABORTION INDUCED | 66 0.66 0.79 ABSCESS | 1 0.01 0.80 ACARODERMATITIS | 1 0.01 0.81 ACCIDENTAL EXPOSURE | 11 0.11 0.92 ACNE | 16 0.16 1.08 ACNE CYSTIC | 1 0.01 1.09 ACQUIRED IMMUNODEFICIENCY SYNDROME | 3 0.03 1.12 ACROMEGALY | 6 0.06 1.18 ACTINIC KERATOSIS | 1 0.01 1.19 ACUTE CORONARY SYNDROME | 9 0.09 1.28 ACUTE LEUKAEMIA | 4 0.04 1.32 ACUTE LYMPHOCYTIC LEUKAEMIA | 8 0.08 1.40 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT | 3 0.03 1.43 ACUTE MYELOID LEUKAEMIA | 27 0.27 1.70 ACUTE MYOCARDIAL INFARCTION | 30 0.30 2.00 ADDISON'S DISEASE | 1 0.01 2.01 ADENOCARCINOMA | 1 0.01 2.02 ADRENAL INSUFFICIENCY | 2 0.02 2.04 ADVERSE DRUG REACTION | 2 0.02 2.06 AFFECT LABILITY | 1 0.01 2.07 AFFECTIVE DISORDER | 4 0.04 2.11 AGGRESSION | 3 0.03 2.14 AGITATION | 7 0.07 2.21 ALCOHOL USE | 2 0.02 2.23 ALCOHOLISM | 1 0.01 2.24 ALLERGIC RESPIRATORY DISEASE | 1 0.01 2.25 ALLERGY PROPHYLAXIS | 1 0.01 2.26 ALLERGY TO ANIMAL | 1 0.01 2.27 ALOPECIA | 4 0.04 2.31 ALPORT'S SYNDROME | 1 0.01 2.32 AMYLOIDOSIS | 6 0.06 2.38 ANAEMIA | 24 0.24 2.62 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 1 0.01 2.63 ANAEMIA OF CHRONIC DISEASE | 1 0.01 2.64 ANAEMIA OF MALIGNANT DISEASE | 2 0.02 2.66 ANAESTHESIA | 9 0.09 2.75 ANAL CANCER METASTATIC | 1 0.01 2.76 ANAL FISTULA | 1 0.01 2.77 ANALGESIC THERAPY | 12 0.12 2.89 ANDROGENETIC ALOPECIA | 1 0.01 2.90 ANGELMAN'S SYNDROME | 2 0.02 2.92 ANGINA PECTORIS | 12 0.12 3.04 ANGINA UNSTABLE | 1 0.01 3.05 ANGIOEDEMA | 1 0.01 3.06 ANGIOGRAM | 2 0.02 3.08 ANGIOLYMPHOID HYPERPLASIA WITH EOSINO.. | 1 0.01 3.09 ANGIOPATHY | 1 0.01 3.10 ANGIOSARCOMA | 3 0.03 3.13 ANKYLOSING SPONDYLITIS | 21 0.21 3.34 ANTACID THERAPY | 1 0.01 3.35 ANTIALLERGIC THERAPY | 3 0.03 3.38 ANTIBIOTIC PROPHYLAXIS | 7 0.07 3.45 ANTIBIOTIC THERAPY | 1 0.01 3.46 ANTICOAGULANT THERAPY | 9 0.09 3.55 ANTIDEPRESSANT THERAPY | 3 0.03 3.58 ANTIEMETIC SUPPORTIVE CARE | 1 0.01 3.59 ANTIFUNGAL PROPHYLAXIS | 12 0.12 3.71 ANTIFUNGAL TREATMENT | 1 0.01 3.72 ANTIINFLAMMATORY THERAPY | 2 0.02 3.74 ANTIPLATELET THERAPY | 5 0.05 3.79 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAP.. | 1 0.01 3.80 ANTIPYRESIS | 2 0.02 3.82 ANTIRETROVIRAL THERAPY | 12 0.12 3.94 ANTITUSSIVE THERAPY | 1 0.01 3.95 ANTIVIRAL PROPHYLAXIS | 14 0.14 4.09 ANURIA | 1 0.01 4.10 ANXIETY | 70 0.70 4.80 ANXIETY DISORDER | 4 0.04 4.84 APLASTIC ANAEMIA | 5 0.05 4.89 APPENDICITIS | 1 0.01 4.90 APTYALISM | 1 0.01 4.91 ARRHYTHMIA | 9 0.09 5.00 ARTERIOGRAM CAROTID | 1 0.01 5.01 ARTERIOSCLEROSIS | 4 0.04 5.05 ARTHRALGIA | 32 0.32 5.37 ARTHRITIS | 27 0.27 5.64 ASPERGER'S DISORDER | 1 0.01 5.65 ASPERGILLOMA | 1 0.01 5.66 ASPERGILLOSIS | 5 0.05 5.71 ASSISTED FERTILISATION | 1 0.01 5.72 ASTHENIA | 1 0.01 5.73 ASTHMA | 117 1.17 6.90 ASTHMATIC CRISIS | 5 0.05 6.95 ATHEROSCLEROSIS PROPHYLAXIS | 1 0.01 6.96 ATRIAL FIBRILLATION | 45 0.45 7.41 ATRIAL FLUTTER | 3 0.03 7.44 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 27 0.27 7.71 ATYPICAL MYCOBACTERIAL INFECTION | 4 0.04 7.75 AUTISM | 4 0.04 7.79 AUTOIMMUNE DISORDER | 1 0.01 7.80 AUTOIMMUNE THYROIDITIS | 2 0.02 7.82 B-CELL LYMPHOMA | 39 0.39 8.21 B-CELL LYMPHOMA STAGE IV | 4 0.04 8.25 BACK DISORDER | 1 0.01 8.26 BACK PAIN | 44 0.44 8.70 BACTERIAL INFECTION | 2 0.02 8.72 BALANCE DISORDER | 1 0.01 8.73 BARRETT'S OESOPHAGUS | 1 0.01 8.74 BASEDOW'S DISEASE | 2 0.02 8.76 BEHCET'S SYNDROME | 10 0.10 8.86 BENIGN PROSTATIC HYPERPLASIA | 21 0.21 9.07 BILE DUCT CANCER | 4 0.04 9.11 BILIARY TRACT INFECTION VIRAL | 2 0.02 9.13 BIPOLAR DISORDER | 40 0.40 9.53 BIPOLAR I DISORDER | 22 0.22 9.75 BLADDER CANCER | 5 0.05 9.80 BLADDER CANCER RECURRENT | 1 0.01 9.81 BLADDER DISORDER | 5 0.05 9.86 BLADDER TRANSITIONAL CELL CARCINOMA | 1 0.01 9.87 BLOOD BICARBONATE DECREASED | 2 0.02 9.89 BLOOD CALCIUM DECREASED | 1 0.01 9.90 BLOOD CHOLESTEROL | 20 0.20 10.10 BLOOD CHOLESTEROL DECREASED | 1 0.01 10.11 BLOOD CHOLESTEROL INCREASED | 66 0.66 10.77 BLOOD CREATINE INCREASED | 1 0.01 10.78 BLOOD CREATINE PHOSPHOKINASE INCREASED | 1 0.01 10.79 BLOOD CREATININE INCREASED | 1 0.01 10.80 BLOOD DISORDER | 2 0.02 10.82 BLOOD GLUCOSE INCREASED | 1 0.01 10.83 BLOOD GROWTH HORMONE | 1 0.01 10.84 BLOOD IMMUNOGLOBULIN E INCREASED | 1 0.01 10.85 BLOOD MAGNESIUM DECREASED | 1 0.01 10.86 BLOOD PHOSPHORUS ABNORMAL | 2 0.02 10.88 BLOOD POTASSIUM DECREASED | 2 0.02 10.90 BLOOD PRESSURE | 30 0.30 11.20 BLOOD PRESSURE ABNORMAL | 6 0.06 11.26 BLOOD PRESSURE INCREASED | 8 0.08 11.34 BLOOD PRESSURE MANAGEMENT | 4 0.04 11.38 BLOOD SODIUM DECREASED | 1 0.01 11.39 BLOOD TESTOSTERONE DECREASED | 2 0.02 11.41 BLOOD TRIGLYCERIDES | 1 0.01 11.42 BLOOD TRIGLYCERIDES INCREASED | 4 0.04 11.46 BLOOD UREA INCREASED | 2 0.02 11.48 BODY HEIGHT BELOW NORMAL | 1 0.01 11.49 BONE CANCER METASTATIC | 1 0.01 11.50 BONE DENSITY DECREASED | 1 0.01 11.51 BONE DISORDER | 6 0.06 11.57 BONE MARROW CONDITIONING REGIMEN | 9 0.09 11.66 BONE PAIN | 2 0.02 11.68 BORDERLINE PERSONALITY DISORDER | 2 0.02 11.70 BOWEL MOVEMENT IRREGULARITY | 2 0.02 11.72 BRADYCARDIA | 1 0.01 11.73 BREAKTHROUGH PAIN | 3 0.03 11.76 BREAST CANCER | 66 0.66 12.42 BREAST CANCER FEMALE | 3 0.03 12.45 BREAST CANCER IN SITU | 1 0.01 12.46 BREAST CANCER METASTATIC | 7 0.07 12.53 BRONCHIECTASIS | 2 0.02 12.55 BRONCHIOLOALVEOLAR CARCINOMA | 2 0.02 12.57 BRONCHITIS | 14 0.14 12.71 BRONCHITIS CHRONIC | 4 0.04 12.75 BRONCHOPNEUMONIA | 2 0.02 12.77 BRONCHOPNEUMOPATHY | 2 0.02 12.79 BRONCHOPULMONARY ASPERGILLOSIS | 6 0.06 12.85 BURKITT'S LYMPHOMA | 14 0.14 12.99 BURN OF INTERNAL ORGANS | 1 0.01 13.00 BURSITIS | 1 0.01 13.01 CALCIUM DEFICIENCY | 1 0.01 13.02 CANCER PAIN | 28 0.28 13.30 CANDIDIASIS | 2 0.02 13.32 CARCINOID SYNDROME | 1 0.01 13.33 CARCINOID TUMOUR | 2 0.02 13.35 CARCINOID TUMOUR OF THE GASTROINTESTI.. | 1 0.01 13.36 CARDIAC DISORDER | 18 0.18 13.54 CARDIAC FAILURE | 18 0.18 13.72 CARDIAC FAILURE ACUTE | 1 0.01 13.73 CARDIAC FAILURE CHRONIC | 2 0.02 13.75 CARDIAC FAILURE CONGESTIVE | 6 0.06 13.81 CARDIAC OPERATION | 4 0.04 13.85 CARDIAC VALVE PROSTHESIS USER | 1 0.01 13.86 CARDIOMYOPATHY | 1 0.01 13.87 CARDIOVASCULAR DISORDER | 3 0.03 13.90 CARDIOVASCULAR EVENT PROPHYLAXIS | 3 0.03 13.93 CARDIOVASCULAR INSUFFICIENCY | 1 0.01 13.94 CAROTID ARTERIOSCLEROSIS | 1 0.01 13.95 CAROTID ARTERY ANEURYSM | 1 0.01 13.96 CASTLEMAN'S DISEASE | 6 0.06 14.02 CATATONIA | 1 0.01 14.03 CATHETERISATION CARDIAC | 1 0.01 14.04 CELLULITIS | 3 0.03 14.07 CENTRAL NERVOUS SYSTEM LESION | 1 0.01 14.08 CEREBRAL INFARCTION | 11 0.11 14.19 CEREBRAL TOXOPLASMOSIS | 3 0.03 14.22 CEREBROVASCULAR ACCIDENT | 1 0.01 14.23 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 2 0.02 14.25 CERVICOBRACHIAL SYNDROME | 1 0.01 14.26 CERVIX CANCER METASTATIC | 2 0.02 14.28 CERVIX CARCINOMA | 6 0.06 14.34 CHEMOTHERAPY | 14 0.14 14.48 CHEST PAIN | 4 0.04 14.52 CHILLBLAINS | 1 0.01 14.53 CHLAMYDIAL INFECTION | 1 0.01 14.54 CHOLECYSTITIS | 1 0.01 14.55 CHOROIDAL NEOVASCULARISATION | 3 0.03 14.58 CHRONIC LYMPHOCYTIC LEUKAEMIA | 24 0.24 14.82 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT | 5 0.05 14.87 CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACT.. | 1 0.01 14.88 CHRONIC MYELOID LEUKAEMIA | 20 0.20 15.08 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 90 0.90 15.98 CHRONIC SINUSITIS | 1 0.01 15.99 CIRCULATORY COLLAPSE | 1 0.01 16.00 COAGULATION TIME PROLONGED | 1 0.01 16.01 COAGULOPATHY | 1 0.01 16.02 COELIAC DISEASE | 2 0.02 16.04 COLITIS | 3 0.03 16.07 COLITIS ULCERATIVE | 31 0.31 16.38 COLLAGEN DISORDER | 1 0.01 16.39 COLON CANCER | 12 0.12 16.51 COLON CANCER METASTATIC | 9 0.09 16.60 COLON CANCER RECURRENT | 1 0.01 16.61 COLONOSCOPY | 7 0.07 16.68 COLORECTAL CANCER | 60 0.60 17.28 COLORECTAL CANCER METASTATIC | 1 0.01 17.29 COLORECTAL CANCER RECURRENT | 2 0.02 17.31 COMPLEMENT FACTOR | 1 0.01 17.32 COMPLEX PARTIAL SEIZURES | 3 0.03 17.35 COMPLICATED MIGRAINE | 1 0.01 17.36 COMPRESSION FRACTURE | 2 0.02 17.38 COMPULSIVE SEXUAL BEHAVIOUR | 1 0.01 17.39 COMPUTERISED TOMOGRAM | 1 0.01 17.40 COMPUTERISED TOMOGRAM THORAX | 1 0.01 17.41 CONDITION AGGRAVATED | 2 0.02 17.43 CONGENITAL APLASTIC ANAEMIA | 1 0.01 17.44 CONJUNCTIVITIS | 7 0.07 17.51 CONJUNCTIVITIS INFECTIVE | 1 0.01 17.52 CONSTIPATION | 45 0.45 17.97 CONSTIPATION PROPHYLAXIS | 2 0.02 17.99 CONTRACEPTION | 48 0.48 18.47 CONVULSION | 23 0.23 18.70 CONVULSION PROPHYLAXIS | 5 0.05 18.75 CORD BLOOD TRANSPLANT THERAPY | 6 0.06 18.81 CORNEAL ABRASION | 1 0.01 18.82 CORONARY ARTERIAL STENT INSERTION | 1 0.01 18.83 CORONARY ARTERY BYPASS | 1 0.01 18.84 CORONARY ARTERY DISEASE | 12 0.12 18.96 CORONARY ARTERY INSUFFICIENCY | 1 0.01 18.97 COUGH | 27 0.27 19.24 CROHN'S DISEASE | 141 1.41 20.65 CUSHING'S SYNDROME | 1 0.01 20.66 CYSTIC FIBROSIS | 1 0.01 20.67 CYSTITIS | 1 0.01 20.68 CYSTITIS INTERSTITIAL | 2 0.02 20.70 CYTOMEGALOVIRUS INFECTION | 1 0.01 20.71 DECREASED ACTIVITY | 1 0.01 20.72 DECREASED APPETITE | 2 0.02 20.74 DEEP VEIN THROMBOSIS | 9 0.09 20.83 DELIRIUM | 4 0.04 20.87 DELIVERY | 4 0.04 20.91 DELUSION | 3 0.03 20.94 DEMENTIA | 10 0.10 21.04 DEMENTIA ALZHEIMER'S TYPE | 17 0.17 21.21 DEMYELINATING POLYNEUROPATHY | 12 0.12 21.33 DENTAL CARE | 2 0.02 21.35 DENTAL DISORDER PROPHYLAXIS | 1 0.01 21.36 DEPRESSED MOOD | 1 0.01 21.37 DEPRESSION | 183 1.83 23.20 DEPRESSIVE SYMPTOM | 1 0.01 23.21 DERMATITIS | 6 0.06 23.27 DERMATITIS ATOPIC | 4 0.04 23.31 DERMATITIS BULLOUS | 1 0.01 23.32 DETOXIFICATION | 1 0.01 23.33 DIABETES INSIPIDUS | 1 0.01 23.34 DIABETES MELLITUS | 230 2.30 25.64 DIABETIC GASTROPARESIS | 1 0.01 25.65 DIABETIC NEUROPATHY | 5 0.05 25.70 DIABETIC RETINAL OEDEMA | 1 0.01 25.71 DIAGNOSTIC PROCEDURE | 1 0.01 25.72 DIALYSIS | 3 0.03 25.75 DIARRHOEA | 9 0.09 25.84 DIFFUSE LARGE B-CELL LYMPHOMA | 13 0.13 25.97 DISBACTERIOSIS | 1 0.01 25.98 DISEASE COMPLICATION | 3 0.03 26.01 DISSEMINATED INTRAVASCULAR COAGULATION | 1 0.01 26.02 DIURETIC THERAPY | 6 0.06 26.08 DIVERTICULITIS | 1 0.01 26.09 DIZZINESS | 7 0.07 26.16 DRUG ABUSE | 4 0.04 26.20 DRUG DEPENDENCE | 5 0.05 26.25 DRUG EFFECT DECREASED | 1 0.01 26.26 DRUG ERUPTION | 4 0.04 26.30 DRUG EXPOSURE DURING PREGNANCY | 29 0.29 26.59 DRUG EXPOSURE VIA BREAST MILK | 1 0.01 26.60 DRUG TOXICITY PROPHYLAXIS | 3 0.03 26.63 DRUG USE FOR UNKNOWN INDICATION | 1,646 16.46 43.09 DRY EYE | 3 0.03 43.12 DRY MOUTH | 2 0.02 43.14 DYSKINESIA | 1 0.01 43.15 DYSLIPIDAEMIA | 6 0.06 43.21 DYSMENORRHOEA | 2 0.02 43.23 DYSPEPSIA | 25 0.25 43.48 DYSPNOEA | 9 0.09 43.57 DYSPNOEA EXERTIONAL | 1 0.01 43.58 DYSTONIA | 1 0.01 43.59 DYSURIA | 3 0.03 43.62 EAR INFECTION | 6 0.06 43.68 EATING DISORDER | 1 0.01 43.69 ECZEMA | 2 0.02 43.71 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 1 0.01 43.72 ELECTROLYTE IMBALANCE | 2 0.02 43.74 EMBOLISM | 1 0.01 43.75 EMPHYSEMA | 10 0.10 43.85 ENCEPHALITIS VIRAL | 1 0.01 43.86 ENCEPHALOPATHY | 1 0.01 43.87 ENDOMETRIAL CANCER | 1 0.01 43.88 ENDOTRACHEAL INTUBATION | 1 0.01 43.89 ENTERAL NUTRITION | 1 0.01 43.90 ENURESIS | 1 0.01 43.91 EPILEPSY | 48 0.48 44.39 ERECTILE DYSFUNCTION | 7 0.07 44.46 EROSIVE OESOPHAGITIS | 2 0.02 44.48 ERYTHEMA | 1 0.01 44.49 ERYTHRODERMIC PSORIASIS | 2 0.02 44.51 ESSENTIAL HYPERTENSION | 9 0.09 44.60 ESSENTIAL THROMBOCYTHAEMIA | 1 0.01 44.61 EVIDENCE BASED TREATMENT | 2 0.02 44.63 EWING'S SARCOMA | 1 0.01 44.64 EXTRANODAL MARGINAL ZONE B-CELL LYMPH.. | 2 0.02 44.66 EXTRASYSTOLES | 1 0.01 44.67 EYE DISORDER | 1 0.01 44.68 EYE INFECTION | 1 0.01 44.69 EYE IRRITATION | 1 0.01 44.70 FABRY'S DISEASE | 4 0.04 44.74 FACE LIFT | 2 0.02 44.76 FACTOR VIII DEFICIENCY | 4 0.04 44.80 FATIGUE | 8 0.08 44.88 FEBRILE CONVULSION | 1 0.01 44.89 FIBROMYALGIA | 8 0.08 44.97 FISTULA | 1 0.01 44.98 FLATULENCE | 1 0.01 44.99 FLUID INTAKE REDUCED | 2 0.02 45.01 FLUID OVERLOAD | 1 0.01 45.02 FLUID REPLACEMENT | 1 0.01 45.03 FLUID RETENTION | 3 0.03 45.06 FOLATE DEFICIENCY | 1 0.01 45.07 FOLLICLE CENTRE LYMPHOMA, FOLLICULAR .. | 3 0.03 45.10 FRACTURE | 1 0.01 45.11 FRACTURE NONUNION | 1 0.01 45.12 FRONTOTEMPORAL DEMENTIA | 4 0.04 45.16 FUNGAL INFECTION | 6 0.06 45.22 FUNGAL SKIN INFECTION | 1 0.01 45.23 GAIT DISTURBANCE | 1 0.01 45.24 GASTRIC BYPASS | 2 0.02 45.26 GASTRIC CANCER | 12 0.12 45.38 GASTRIC DISORDER | 20 0.20 45.58 GASTRIC MUCOSAL LESION | 1 0.01 45.59 GASTRIC ULCER | 5 0.05 45.64 GASTRIC ULCER HAEMORRHAGE | 1 0.01 45.65 GASTRITIS | 12 0.12 45.77 GASTRITIS PROPHYLAXIS | 5 0.05 45.82 GASTROENTERITIS | 5 0.05 45.87 GASTROINTESTINAL DISORDER | 7 0.07 45.94 GASTROINTESTINAL HAEMORRHAGE | 4 0.04 45.98 GASTROINTESTINAL MUCOSAL DISORDER | 1 0.01 45.99 GASTROINTESTINAL NEOPLASM | 1 0.01 46.00 GASTROINTESTINAL STROMAL TUMOUR | 5 0.05 46.05 GASTROINTESTINAL ULCER | 1 0.01 46.06 GASTROOESOPHAGEAL CANCER | 10 0.10 46.16 GASTROOESOPHAGEAL REFLUX DISEASE | 39 0.39 46.55 GAUCHER'S DISEASE | 3 0.03 46.58 GENERAL ANAESTHESIA | 8 0.08 46.66 GENERALISED ANXIETY DISORDER | 3 0.03 46.69 GESTATIONAL DIABETES | 2 0.02 46.71 GLAUCOMA | 13 0.13 46.84 GLAUCOMA SURGERY | 2 0.02 46.86 GLIOBLASTOMA | 1 0.01 46.87 GLIOBLASTOMA MULTIFORME | 3 0.03 46.90 GLYCOGEN STORAGE DISEASE TYPE II | 4 0.04 46.94 GOUT | 14 0.14 47.08 GRAFT VERSUS HOST DISEASE | 7 0.07 47.15 GRAND MAL CONVULSION | 6 0.06 47.21 GROWTH HORMONE DEFICIENCY | 5 0.05 47.26 H1N1 INFLUENZA | 1 0.01 47.27 HAEMATOLOGICAL MALIGNANCY | 4 0.04 47.31 HAEMATOPOIETIC NEOPLASM | 1 0.01 47.32 HAEMATOPOIETIC STEM CELL MOBILISATION | 1 0.01 47.33 HAEMOCHROMATOSIS | 2 0.02 47.35 HAEMODIALYSIS | 1 0.01 47.36 HAEMOLYTIC ANAEMIA | 2 0.02 47.38 HAEMOPHILIA | 26 0.26 47.64 HAEMOPHILIA B WITHOUT INHIBITORS | 1 0.01 47.65 HAEMOPHILIC ARTHROPATHY | 1 0.01 47.66 HAEMORRHAGE | 1 0.01 47.67 HAEMOSIDEROSIS | 1 0.01 47.68 HAIRY CELL LEUKAEMIA | 3 0.03 47.71 HALLUCINATION | 4 0.04 47.75 HALLUCINATION, AUDITORY | 2 0.02 47.77 HEAD AND NECK CANCER | 12 0.12 47.89 HEADACHE | 31 0.31 48.20 HEART DISEASE CONGENITAL | 4 0.04 48.24 HEART RATE ABNORMAL | 1 0.01 48.25 HEART RATE INCREASED | 1 0.01 48.26 HEART RATE IRREGULAR | 1 0.01 48.27 HEART TRANSPLANT | 2 0.02 48.29 HEPATIC NEOPLASM MALIGNANT | 8 0.08 48.37 HEPATIC STEATOSIS | 1 0.01 48.38 HEPATITIS B | 10 0.10 48.48 HEPATITIS C | 25 0.25 48.73 HEREDITARY HAEMOCHROMATOSIS | 1 0.01 48.74 HERNIA | 1 0.01 48.75 HERPES VIRUS INFECTION | 1 0.01 48.76 HERPES ZOSTER | 3 0.03 48.79 HIATUS HERNIA | 1 0.01 48.80 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 48.81 HIP ARTHROPLASTY | 1 0.01 48.82 HISTIOCYTOSIS HAEMATOPHAGIC | 3 0.03 48.85 HIV INFECTION | 185 1.85 50.70 HIV INFECTION CDC CATEGORY C3 | 3 0.03 50.73 HODGKIN'S DISEASE | 4 0.04 50.77 HORMONE REPLACEMENT THERAPY | 22 0.22 50.99 HORMONE THERAPY | 5 0.05 51.04 HOT FLUSH | 1 0.01 51.05 HOUSE DUST ALLERGY | 1 0.01 51.06 HUMAN IMMUNODEFICIENCY VIRUS TRANSMIS.. | 2 0.02 51.08 HUNTINGTON'S CHOREA | 1 0.01 51.09 HYDROCEPHALUS | 2 0.02 51.11 HYPERCALCAEMIA | 5 0.05 51.16 HYPERCALCAEMIA OF MALIGNANCY | 1 0.01 51.17 HYPERCHLORHYDRIA | 3 0.03 51.20 HYPERCHOLESTEROLAEMIA | 32 0.32 51.52 HYPERGLYCAEMIA | 2 0.02 51.54 HYPERLIPIDAEMIA | 25 0.25 51.79 HYPERPARATHYROIDISM SECONDARY | 5 0.05 51.84 HYPERPHAGIA | 1 0.01 51.85 HYPERPHOSPHATAEMIA | 6 0.06 51.91 HYPERSENSITIVITY | 18 0.18 52.09 HYPERTENSION | 414 4.14 56.23 HYPERTHYROIDISM | 6 0.06 56.29 HYPERTONIC BLADDER | 3 0.03 56.32 HYPERURICAEMIA | 7 0.07 56.39 HYPOAESTHESIA | 1 0.01 56.40 HYPOALBUMINAEMIA | 1 0.01 56.41 HYPOCALCAEMIA | 2 0.02 56.43 HYPOKALAEMIA | 4 0.04 56.47 HYPOMANIA | 1 0.01 56.48 HYPONATRAEMIA | 1 0.01 56.49 HYPOTENSION | 1 0.01 56.50 HYPOTHYROIDISM | 31 0.31 56.81 HYPOVITAMINOSIS | 3 0.03 56.84 HYSTERECTOMY | 1 0.01 56.85 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 47 0.47 57.32 ILEUS | 3 0.03 57.35 ILL-DEFINED DISORDER | 2 0.02 57.37 IMMUNISATION | 6 0.06 57.43 IMMUNODEFICIENCY | 1 0.01 57.44 IMMUNOSUPPRESSION | 14 0.14 57.58 IMPAIRED GASTRIC EMPTYING | 1 0.01 57.59 IN VITRO FERTILISATION | 1 0.01 57.60 INCONTINENCE | 1 0.01 57.61 INDUCTION OF ANAESTHESIA | 5 0.05 57.66 INFANTILE SPASMS | 4 0.04 57.70 INFECTION | 10 0.10 57.80 INFECTION PROPHYLAXIS | 13 0.13 57.93 INFLAMMATION | 2 0.02 57.95 INFLAMMATORY BOWEL DISEASE | 7 0.07 58.02 INFLUENZA | 21 0.21 58.23 INFLUENZA LIKE ILLNESS | 2 0.02 58.25 INSOMNIA | 42 0.42 58.67 INTENTIONAL DRUG MISUSE | 2 0.02 58.69 INTENTIONAL OVERDOSE | 1 0.01 58.70 INTERMITTENT EXPLOSIVE DISORDER | 1 0.01 58.71 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 58.72 INTERVERTEBRAL DISC PROTRUSION | 2 0.02 58.74 INTESTINAL STENOSIS | 1 0.01 58.75 INTRAOCULAR LENS IMPLANT | 1 0.01 58.76 INTRAOCULAR PRESSURE INCREASED | 2 0.02 58.78 INTRAOPERATIVE CARE | 1 0.01 58.79 IRITIS | 1 0.01 58.80 IRON DEFICIENCY | 1 0.01 58.81 IRON DEFICIENCY ANAEMIA | 8 0.08 58.89 IRON OVERLOAD | 11 0.11 59.00 IRRITABLE BOWEL SYNDROME | 6 0.06 59.06 ISCHAEMIC CARDIOMYOPATHY | 1 0.01 59.07 ISCHAEMIC STROKE | 1 0.01 59.08 JAUNDICE | 1 0.01 59.09 JOINT SWELLING | 1 0.01 59.10 JUVENILE ARTHRITIS | 8 0.08 59.18 KIDNEY TRANSPLANT REJECTION | 1 0.01 59.19 LABOUR STIMULATION | 8 0.08 59.27 LARGE INTESTINE CARCINOMA | 7 0.07 59.34 LAXATIVE SUPPORTIVE CARE | 2 0.02 59.36 LENNOX-GASTAUT SYNDROME | 4 0.04 59.40 LETHARGY | 1 0.01 59.41 LEUKAEMIA | 3 0.03 59.44 LINEAR IGA DISEASE | 4 0.04 59.48 LIPIDS | 1 0.01 59.49 LIPIDS INCREASED | 1 0.01 59.50 LIVER DISORDER | 2 0.02 59.52 LIVER TRANSPLANT | 17 0.17 59.69 LOCAL ANAESTHESIA | 3 0.03 59.72 LOWER RESPIRATORY TRACT INFECTION | 1 0.01 59.73 LUMBAR SPINAL STENOSIS | 1 0.01 59.74 LUNG ADENOCARCINOMA | 2 0.02 59.76 LUNG ADENOCARCINOMA RECURRENT | 1 0.01 59.77 LUNG ADENOCARCINOMA STAGE III | 1 0.01 59.78 LUNG DISORDER | 8 0.08 59.86 LUNG INFECTION | 2 0.02 59.88 LUNG INFECTION PSEUDOMONAL | 1 0.01 59.89 LUNG NEOPLASM MALIGNANT | 3 0.03 59.92 LYMPHATIC DISORDER | 2 0.02 59.94 LYMPHATIC SYSTEM NEOPLASM | 1 0.01 59.95 LYMPHOMA | 1 0.01 59.96 MACULAR DEGENERATION | 23 0.23 60.19 MACULAR OEDEMA | 1 0.01 60.20 MAINTENANCE OF ANAESTHESIA | 2 0.02 60.22 MAJOR DEPRESSION | 8 0.08 60.30 MALAISE | 2 0.02 60.32 MALARIA | 2 0.02 60.34 MALIGNANT HYPERTENSION | 3 0.03 60.37 MALIGNANT LYMPHOID NEOPLASM | 8 0.08 60.45 MALIGNANT MELANOMA | 2 0.02 60.47 MANIA | 11 0.11 60.58 MANTLE CELL LYMPHOMA | 5 0.05 60.63 MANTLE CELL LYMPHOMA REFRACTORY | 1 0.01 60.64 MASS | 1 0.01 60.65 MASTECTOMY | 2 0.02 60.67 MASTITIS BACTERIAL | 1 0.01 60.68 MASTOCYTOSIS | 1 0.01 60.69 MEDICAL DIET | 12 0.12 60.81 MEDULLOBLASTOMA | 2 0.02 60.83 MEDULLOBLASTOMA RECURRENT | 2 0.02 60.85 MEMORY IMPAIRMENT | 2 0.02 60.87 MENINGITIS BACTERIAL | 1 0.01 60.88 MENINGITIS VIRAL | 1 0.01 60.89 MENOPAUSAL SYMPTOMS | 1 0.01 60.90 MENOPAUSE | 3 0.03 60.93 MENORRHAGIA | 2 0.02 60.95 MENSTRUAL DISORDER | 1 0.01 60.96 MENTAL DISORDER | 1 0.01 60.97 METABOLIC SYNDROME | 1 0.01 60.98 METASTASES TO BONE | 7 0.07 61.05 METASTASES TO CHEST WALL | 1 0.01 61.06 METASTATIC CARCINOID TUMOUR | 3 0.03 61.09 METASTATIC GASTRIC CANCER | 4 0.04 61.13 METASTATIC MALIGNANT MELANOMA | 2 0.02 61.15 METASTATIC PAIN | 1 0.01 61.16 METASTATIC RENAL CELL CARCINOMA | 32 0.32 61.48 MICTURITION URGENCY | 1 0.01 61.49 MIDDLE EAR INFLAMMATION | 1 0.01 61.50 MIGRAINE | 18 0.18 61.68 MIGRAINE PROPHYLAXIS | 6 0.06 61.74 MIGRAINE WITH AURA | 1 0.01 61.75 MIGRAINE WITHOUT AURA | 1 0.01 61.76 MINERAL SUPPLEMENTATION | 9 0.09 61.85 MOBILITY DECREASED | 1 0.01 61.86 MOOD ALTERED | 1 0.01 61.87 MULTI-ORGAN DISORDER | 1 0.01 61.88 MULTI-ORGAN FAILURE | 1 0.01 61.89 MULTIPLE ALLERGIES | 1 0.01 61.90 MULTIPLE MYELOMA | 132 1.32 63.22 MULTIPLE SCLEROSIS | 614 6.14 69.36 MULTIPLE SCLEROSIS RELAPSE | 3 0.03 69.39 MUSCLE ATROPHY | 1 0.01 69.40 MUSCLE RELAXANT THERAPY | 7 0.07 69.47 MUSCLE SPASMS | 14 0.14 69.61 MUSCLE SPASTICITY | 6 0.06 69.67 MUSCULOSKELETAL PAIN | 10 0.10 69.77 MYALGIA | 4 0.04 69.81 MYASTHENIC SYNDROME | 1 0.01 69.82 MYCOBACTERIUM ABSCESSUS INFECTION | 3 0.03 69.85 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 1 0.01 69.86 MYCOPLASMA INFECTION | 2 0.02 69.88 MYELODYSPLASTIC SYNDROME | 11 0.11 69.99 MYELOFIBROSIS | 1 0.01 70.00 MYELOID LEUKAEMIA | 2 0.02 70.02 MYELOMA RECURRENCE | 2 0.02 70.04 MYELOPROLIFERATIVE DISORDER | 1 0.01 70.05 MYOCARDIAL INFARCTION | 3 0.03 70.08 MYOCARDIAL ISCHAEMIA | 10 0.10 70.18 NARCOLEPSY | 8 0.08 70.26 NASAL CONGESTION | 7 0.07 70.33 NASAL POLYPS | 1 0.01 70.34 NASOPHARYNGITIS | 29 0.29 70.63 NAUSEA | 34 0.34 70.97 NECK MASS | 1 0.01 70.98 NECK PAIN | 4 0.04 71.02 NEOPLASM | 10 0.10 71.12 NEOPLASM MALIGNANT | 5 0.05 71.17 NEOPLASM RECURRENCE | 2 0.02 71.19 NEPHRITIS | 1 0.01 71.20 NEPHROTIC SYNDROME | 5 0.05 71.25 NERVE BLOCK | 2 0.02 71.27 NERVE COMPRESSION | 1 0.01 71.28 NERVE INJURY | 1 0.01 71.29 NERVOUS SYSTEM DISORDER | 4 0.04 71.33 NERVOUSNESS | 3 0.03 71.36 NEURALGIA | 14 0.14 71.50 NEUROENDOCRINE CARCINOMA | 2 0.02 71.52 NEUROENDOCRINE TUMOUR | 9 0.09 71.61 NEUROPATHY PERIPHERAL | 8 0.08 71.69 NEUTROPENIA | 4 0.04 71.73 NICOTINE DEPENDENCE | 1 0.01 71.74 NOCTURIA | 1 0.01 71.75 NON-HODGKIN'S LYMPHOMA | 18 0.18 71.93 NON-SMALL CELL LUNG CANCER | 71 0.71 72.64 NON-SMALL CELL LUNG CANCER STAGE IV | 6 0.06 72.70 NORMAL TENSION GLAUCOMA | 1 0.01 72.71 NUCLEAR MAGNETIC RESONANCE IMAGING | 7 0.07 72.78 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 5 0.05 72.83 NUTRITIONAL SUPPORT | 3 0.03 72.86 OBESITY | 5 0.05 72.91 OBSESSIVE THOUGHTS | 2 0.02 72.93 OBSESSIVE-COMPULSIVE DISORDER | 2 0.02 72.95 OEDEMA | 4 0.04 72.99 OEDEMA DUE TO CARDIAC DISEASE | 1 0.01 73.00 OEDEMA PERIPHERAL | 1 0.01 73.01 OESOPHAGEAL ADENOCARCINOMA | 6 0.06 73.07 OESOPHAGEAL CARCINOMA | 2 0.02 73.09 OESOPHAGITIS | 1 0.01 73.10 OFF LABEL USE | 13 0.13 73.23 ON AND OFF PHENOMENON | 1 0.01 73.24 ONYCHOMYCOSIS | 4 0.04 73.28 OPPORTUNISTIC INFECTION PROPHYLAXIS | 2 0.02 73.30 OPTIC NERVE DISORDER | 1 0.01 73.31 ORAL CONTRACEPTION | 2 0.02 73.33 ORAL HERPES | 2 0.02 73.35 OROPHARYNGEAL PAIN | 4 0.04 73.39 OSTEITIS | 2 0.02 73.41 OSTEITIS DEFORMANS | 1 0.01 73.42 OSTEOARTHRITIS | 27 0.27 73.69 OSTEOCHONDROSIS | 4 0.04 73.73 OSTEOMYELITIS | 1 0.01 73.74 OSTEOPENIA | 18 0.18 73.92 OSTEOPETROSIS | 1 0.01 73.93 OSTEOPOROSIS | 187 1.87 75.80 OSTEOPOROSIS POSTMENOPAUSAL | 20 0.20 76.00 OSTEOPOROSIS PROPHYLAXIS | 4 0.04 76.04 OTITIS MEDIA | 2 0.02 76.06 OVARIAN CANCER | 7 0.07 76.13 OVARIAN CANCER RECURRENT | 3 0.03 76.16 OVERWEIGHT | 1 0.01 76.17 OVULATION INDUCTION | 1 0.01 76.18 PAIN | 151 1.51 77.69 PAIN IN EXTREMITY | 10 0.10 77.79 PAIN IN JAW | 1 0.01 77.80 PAIN MANAGEMENT | 7 0.07 77.87 PAIN PROPHYLAXIS | 1 0.01 77.88 PALPITATIONS | 2 0.02 77.90 PANCREATIC CARCINOMA | 3 0.03 77.93 PANCREATIC INSUFFICIENCY | 2 0.02 77.95 PANCREATITIS | 1 0.01 77.96 PANCREATOGENOUS DIABETES | 2 0.02 77.98 PANIC ATTACK | 1 0.01 77.99 PANIC DISORDER | 1 0.01 78.00 PANNICULITIS | 2 0.02 78.02 PARANOIA | 2 0.02 78.04 PARKINSON'S DISEASE | 41 0.41 78.45 PARKINSONISM | 2 0.02 78.47 PAROPHTHALMIA | 1 0.01 78.48 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 7 0.07 78.55 PARTIAL SEIZURES | 6 0.06 78.61 PEMPHIGOID | 1 0.01 78.62 PEMPHIGUS | 1 0.01 78.63 PERCUTANEOUS CORONARY INTERVENTION | 4 0.04 78.67 PERICARDIAL EFFUSION | 1 0.01 78.68 PERIODONTAL DISEASE | 1 0.01 78.69 PERIODONTITIS | 3 0.03 78.72 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 1 0.01 78.73 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED | 1 0.01 78.74 PERIPHERAL VASCULAR DISORDER | 1 0.01 78.75 PERITONEAL DIALYSIS | 109 1.09 79.84 PERITONEAL INFECTION | 1 0.01 79.85 PERITONEAL TUBERCULOSIS | 8 0.08 79.93 PERSONALITY DISORDER | 1 0.01 79.94 PHARYNGITIS | 7 0.07 80.01 PHLEBITIS | 1 0.01 80.02 PLASMACYTOMA | 2 0.02 80.04 PLASMODIUM FALCIPARUM INFECTION | 1 0.01 80.05 PLATELET DISORDER | 1 0.01 80.06 PLEURAL EFFUSION | 2 0.02 80.08 PNEUMOCYSTIS JIROVECI INFECTION | 2 0.02 80.10 PNEUMONIA | 30 0.30 80.40 PNEUMONIA ASPIRATION | 1 0.01 80.41 PNEUMONIA FUNGAL | 1 0.01 80.42 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 80.43 PNEUMONITIS | 1 0.01 80.44 POLLAKIURIA | 4 0.04 80.48 POLYARTERITIS NODOSA | 3 0.03 80.51 POLYARTHRITIS | 2 0.02 80.53 POLYCYSTIC OVARIES | 2 0.02 80.55 POLYNEUROPATHY | 1 0.01 80.56 POLYURIA | 3 0.03 80.59 POOR QUALITY SLEEP | 1 0.01 80.60 PORTAL VEIN THROMBOSIS | 1 0.01 80.61 POST HERPETIC NEURALGIA | 3 0.03 80.64 POST PROCEDURAL INFECTION | 1 0.01 80.65 POST-TRAUMATIC STRESS DISORDER | 1 0.01 80.66 POSTMENOPAUSE | 1 0.01 80.67 POSTOPERATIVE ANALGESIA | 2 0.02 80.69 POSTOPERATIVE CARE | 14 0.14 80.83 POSTOPERATIVE ILEUS | 1 0.01 80.84 POSTPARTUM HAEMORRHAGE | 1 0.01 80.85 PRECOCIOUS PUBERTY | 1 0.01 80.86 PREGNANCY | 2 0.02 80.88 PREMEDICATION | 40 0.40 81.28 PREOPERATIVE CARE | 1 0.01 81.29 PRIMARY IMMUNODEFICIENCY SYNDROME | 1 0.01 81.30 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS | 1 0.01 81.31 PROCEDURAL PAIN | 6 0.06 81.37 PROCTOCOLITIS | 1 0.01 81.38 PROGESTERONE | 1 0.01 81.39 PROPHYLAXIS | 176 1.76 83.15 PROPHYLAXIS AGAINST DEHYDRATION | 1 0.01 83.16 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 22 0.22 83.38 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 9 0.09 83.47 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 16 0.16 83.63 PROPHYLAXIS OF NAUSEA AND VOMITING | 4 0.04 83.67 PROSTATE CANCER | 52 0.52 84.19 PROSTATE CANCER METASTATIC | 4 0.04 84.23 PROSTATE CANCER STAGE II | 2 0.02 84.25 PROSTATE CANCER STAGE III | 5 0.05 84.30 PROSTATE CANCER STAGE IV | 10 0.10 84.40 PROSTATIC ADENOMA | 1 0.01 84.41 PROSTATIC DISORDER | 1 0.01 84.42 PROSTATITIS | 2 0.02 84.44 PROSTATOMEGALY | 5 0.05 84.49 PRURITUS | 5 0.05 84.54 PSEUDOMONAS INFECTION | 2 0.02 84.56 PSORIASIS | 36 0.36 84.92 PSORIATIC ARTHROPATHY | 30 0.30 85.22 PSYCHIATRIC SYMPTOM | 3 0.03 85.25 PSYCHOMOTOR HYPERACTIVITY | 2 0.02 85.27 PSYCHOTIC DISORDER | 18 0.18 85.45 PULMONARY ARTERIAL HYPERTENSION | 51 0.51 85.96 PULMONARY EMBOLISM | 7 0.07 86.03 PULMONARY HYPERTENSION | 8 0.08 86.11 PULMONARY SARCOIDOSIS | 4 0.04 86.15 PULMONARY VASCULAR DISORDER | 1 0.01 86.16 PYELONEPHRITIS | 4 0.04 86.20 PYREXIA | 59 0.59 86.79 RASH | 12 0.12 86.91 RASH GENERALISED | 3 0.03 86.94 RASH PRURITIC | 1 0.01 86.95 RECTAL CANCER | 11 0.11 87.06 RECTAL CANCER METASTATIC | 17 0.17 87.23 REFLUX GASTRITIS | 3 0.03 87.26 REFLUX OESOPHAGITIS | 3 0.03 87.29 RELAPSING FEVER | 1 0.01 87.30 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 14 0.14 87.44 RENAL CANCER | 5 0.05 87.49 RENAL CANCER METASTATIC | 2 0.02 87.51 RENAL CELL CARCINOMA | 43 0.43 87.94 RENAL FAILURE | 8 0.08 88.02 RENAL FAILURE ACUTE | 1 0.01 88.03 RENAL FAILURE CHRONIC | 24 0.24 88.27 RENAL IMPAIRMENT | 3 0.03 88.30 RENAL TRANSPLANT | 39 0.39 88.69 RESIDUAL URINE | 1 0.01 88.70 RESPIRATORY DISORDER | 9 0.09 88.79 RESPIRATORY MONILIASIS | 1 0.01 88.80 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 3 0.03 88.83 RESPIRATORY TRACT CONGESTION | 1 0.01 88.84 RESPIRATORY TRACT INFECTION | 2 0.02 88.86 RESTLESS LEGS SYNDROME | 10 0.10 88.96 RESTLESSNESS | 1 0.01 88.97 RETINAL VEIN OCCLUSION | 1 0.01 88.98 RHEUMATOID ARTHRITIS | 305 3.05 92.03 RHEUMATOID VASCULITIS | 1 0.01 92.04 RHINITIS | 1 0.01 92.05 RHINITIS ALLERGIC | 7 0.07 92.12 RHINORRHOEA | 4 0.04 92.16 ROSACEA | 4 0.04 92.20 ROUTINE HEALTH MAINTENANCE | 3 0.03 92.23 SALIVARY HYPERSECRETION | 1 0.01 92.24 SARCOIDOSIS | 3 0.03 92.27 SARCOMA | 4 0.04 92.31 SCAN MYOCARDIAL PERFUSION | 2 0.02 92.33 SCHIZOAFFECTIVE DISORDER | 20 0.20 92.53 SCHIZOPHRENIA | 76 0.76 93.29 SCHIZOPHRENIA, DISORGANISED TYPE | 2 0.02 93.31 SCHIZOPHRENIA, PARANOID TYPE | 9 0.09 93.40 SCIATICA | 1 0.01 93.41 SCLERODERMA | 3 0.03 93.44 SEASONAL ALLERGY | 5 0.05 93.49 SECONDARY HYPOGONADISM | 1 0.01 93.50 SECONDARY HYPOTHYROIDISM | 1 0.01 93.51 SECONDARY IMMUNODEFICIENCY | 1 0.01 93.52 SEDATION | 10 0.10 93.62 SELF INJURIOUS BEHAVIOUR | 2 0.02 93.64 SEMINOMA | 3 0.03 93.67 SEPSIS | 10 0.10 93.77 SEPTIC EMBOLUS | 6 0.06 93.83 SEPTIC SHOCK | 1 0.01 93.84 SERONEGATIVE ARTHRITIS | 1 0.01 93.85 SHOCK | 4 0.04 93.89 SINUS CONGESTION | 6 0.06 93.95 SINUS DISORDER | 1 0.01 93.96 SINUS HEADACHE | 3 0.03 93.99 SINUSITIS | 14 0.14 94.13 SJOGREN'S SYNDROME | 2 0.02 94.15 SKIN BURNING SENSATION | 1 0.01 94.16 SKIN INFECTION | 1 0.01 94.17 SKIN LESION | 1 0.01 94.18 SKIN WRINKLING | 3 0.03 94.21 SLEEP DISORDER | 30 0.30 94.51 SLEEP DISORDER THERAPY | 4 0.04 94.55 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 5 0.05 94.60 SMALL INTESTINAL OBSTRUCTION | 1 0.01 94.61 SMOKING CESSATION THERAPY | 38 0.38 94.99 SOCIAL PHOBIA | 2 0.02 95.01 SOMNOLENCE | 1 0.01 95.02 SPINAL ANAESTHESIA | 1 0.01 95.03 SPINAL COLUMN STENOSIS | 3 0.03 95.06 SPINAL CORD COMPRESSION | 1 0.01 95.07 SPINAL FRACTURE | 1 0.01 95.08 SPINAL OSTEOARTHRITIS | 7 0.07 95.15 STAPHYLOCOCCAL INFECTION | 8 0.08 95.23 STAPHYLOCOCCAL SEPSIS | 5 0.05 95.28 STATUS EPILEPTICUS | 1 0.01 95.29 STEM CELL TRANSPLANT | 20 0.20 95.49 STENT PLACEMENT | 7 0.07 95.56 STOMATITIS | 1 0.01 95.57 STREPTOCOCCAL INFECTION | 1 0.01 95.58 STREPTOCOCCAL SEPSIS | 2 0.02 95.60 STRESS | 1 0.01 95.61 STRESS ULCER | 1 0.01 95.62 SUBENDOCARDIAL ISCHAEMIA | 1 0.01 95.63 SUPPLEMENTATION THERAPY | 25 0.25 95.88 SUPRAVENTRICULAR EXTRASYSTOLES | 1 0.01 95.89 SUPRAVENTRICULAR TACHYCARDIA | 13 0.13 96.02 SURGERY | 1 0.01 96.03 SWELLING | 1 0.01 96.04 SWOLLEN TONGUE | 1 0.01 96.05 SYNCOPE | 1 0.01 96.06 SYSTEMIC LUPUS ERYTHEMATOSUS | 18 0.18 96.24 SYSTEMIC LUPUS ERYTHEMATOSUS RASH | 1 0.01 96.25 T-CELL LYMPHOMA | 1 0.01 96.26 TACHYCARDIA | 5 0.05 96.31 TACHYCARDIA PAROXYSMAL | 4 0.04 96.35 TEETHING | 9 0.09 96.44 TENDON INJURY | 1 0.01 96.45 TENDONITIS | 1 0.01 96.46 TESTICULAR SEMINOMA (PURE) | 3 0.03 96.49 TESTIS CANCER | 3 0.03 96.52 THALASSAEMIA | 1 0.01 96.53 THALASSAEMIA BETA | 4 0.04 96.57 THERAPEUTIC PROCEDURE | 3 0.03 96.60 THROMBOCYTOPENIA | 5 0.05 96.65 THROMBOCYTOPENIA NEONATAL | 1 0.01 96.66 THROMBOCYTOPENIC PURPURA | 3 0.03 96.69 THROMBOPHLEBITIS | 1 0.01 96.70 THROMBOSIS | 3 0.03 96.73 THROMBOSIS PROPHYLAXIS | 33 0.33 97.06 THYROID CANCER | 7 0.07 97.13 THYROID CANCER METASTATIC | 1 0.01 97.14 THYROID DISORDER | 13 0.13 97.27 THYROID HORMONE REPLACEMENT THERAPY | 1 0.01 97.28 THYROIDECTOMY | 1 0.01 97.29 TINEA INFECTION | 1 0.01 97.30 TINEA PEDIS | 1 0.01 97.31 TOBACCO ABUSE | 2 0.02 97.33 TONGUE NEOPLASM MALIGNANT STAGE UNSPE.. | 1 0.01 97.34 TONSILLITIS | 1 0.01 97.35 TOOTH INFECTION | 1 0.01 97.36 TOOTHACHE | 2 0.02 97.38 TORTICOLLIS | 2 0.02 97.40 TRACHEOBRONCHITIS | 1 0.01 97.41 TRANSIENT ISCHAEMIC ATTACK | 1 0.01 97.42 TRANSITIONAL CELL CARCINOMA | 1 0.01 97.43 TRAUMATIC HAEMORRHAGE | 1 0.01 97.44 TREMOR | 2 0.02 97.46 TRICHOPHYTIC GRANULOMA | 1 0.01 97.47 TRIGEMINAL NEURALGIA | 2 0.02 97.49 TUBEROUS SCLEROSIS | 1 0.01 97.50 TUBULOINTERSTITIAL NEPHRITIS | 2 0.02 97.52 TYPE 1 DIABETES MELLITUS | 5 0.05 97.57 TYPE 2 DIABETES MELLITUS | 123 1.23 98.80 TYPE IIA HYPERLIPIDAEMIA | 1 0.01 98.81 TYPHOID FEVER | 1 0.01 98.82 ULCERATIVE KERATITIS | 2 0.02 98.84 UNEVALUABLE EVENT | 1 0.01 98.85 UPPER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 98.86 UPPER RESPIRATORY TRACT INFECTION | 7 0.07 98.93 UPPER RESPIRATORY TRACT INFLAMMATION | 3 0.03 98.96 URINARY INCONTINENCE | 2 0.02 98.98 URINARY RETENTION | 1 0.01 98.99 URINARY TRACT DISORDER | 1 0.01 99.00 URINARY TRACT INFECTION | 15 0.15 99.15 URTICARIA | 6 0.06 99.21 URTICARIA CHRONIC | 2 0.02 99.23 UTERINE CANCER | 1 0.01 99.24 UVEITIS | 1 0.01 99.25 VAGINITIS BACTERIAL | 1 0.01 99.26 VARICOSE VEIN | 3 0.03 99.29 VASCULITIS | 2 0.02 99.31 VEIN DISORDER | 1 0.01 99.32 VENOUS INSUFFICIENCY | 2 0.02 99.34 VENOUS THROMBOSIS | 1 0.01 99.35 VENTRICULAR FIBRILLATION | 2 0.02 99.37 VENTRICULAR HYPERTROPHY | 2 0.02 99.39 VERTIGO | 2 0.02 99.41 VIRAL INFECTION | 1 0.01 99.42 VIRAL TEST POSITIVE | 2 0.02 99.44 VITAMIN B12 DEFICIENCY | 1 0.01 99.45 VITAMIN D DEFICIENCY | 1 0.01 99.46 VITAMIN SUPPLEMENTATION | 14 0.14 99.60 VOMITING | 12 0.12 99.72 VULVOVAGINAL BURNING SENSATION | 1 0.01 99.73 VULVOVAGINAL DRYNESS | 3 0.03 99.76 WALDENSTROM'S MACROGLOBULINAEMIA | 10 0.10 99.86 WEIGHT CONTROL | 2 0.02 99.88 WEIGHT DECREASED | 3 0.03 99.91 WEIGHT LOSS DIET | 1 0.01 99.92 WHEEZING | 4 0.04 99.96 WHIPPLE'S DISEASE | 3 0.03 99.99 WHITE BLOOD CELL COUNT | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015